Janssen, the pharmaceutical division of the Johnson & Johnson companies, announced Wednesday that it will scrap development of a vaccine for respiratory syncytial virus, or RSV, in adults.
from CNN.com - RSS Channel - HP Hero https://ift.tt/TGtxHUp
via IFTTT
0 comments:
Post a Comment